Design and Synthesis of Novel Candidate CK1δ Proteolysis Targeting Chimeras (PROTACs)
Preprint
- 31 October 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Dysregulation of CK1 isoforms is linked to various types of diseases, including neuro-degeneration and different types of neoplasia such as colon-, pancreatic-, breast-, and ovarian cancer. For CK1 isoforms, a plethora of effective small molecule inhibitors are available. However, only a few degraders of CK1α and, more recently, PROteolysis TArgeting Chimeras (PROTACs) for CK1δ/CK1ε have been reported. In this study, we applied the PROTAC concept by harnessing molecular modeling to design and synthe-size a series of candidate CK1δ-targeting PROTACs based on a highly specific and po-tent benzothiazole-based CK1δ-inhibitor that we previously developed in our lab. In the present study, we established a modular synthetic platform to systematically gen-erate a set of PROTAC degrader candidates consisting of the CK1δ-specific inhibitor scaffold, alkyl- and PEG-linker motifs with various lengths, and Cereblon (CRBN)-engaging pomalidomide and thalidomide derivatives as E3 ligase binders. We demonstrate that several PROTACs degrade CK1δ/ε in various cells. The most potent PROTAC P1d inhibits the phosphorylation of downstream substrates through CK1δ/ε degradation. We establish the requirement of CUL4ACRBN and the proteasome for P1d-mediated degradation of CK1δ/ε.Keywords
All Related Versions
- Version 1, 2025-10-31, Preprints
- Published version: Molecules, 30 (22), 4452.
This publication has 51 references indexed in Scilit:
- Discovery of novel co-degradation CK1α and CDK7/9 PROTACs with p53 activation for treating acute myeloid leukemiaBioorganic Chemistry, 2024
- PROTACs: An Emerging Therapeutic Modality in Precision MedicineCell Chemical Biology, 2020
- Targeted protein degradation: elements of PROTAC designCurrent Opinion in Chemical Biology, 2019
- Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugsEBioMedicine, 2018
- Dishevelled at the Crossroads of Pathways2014
- Substrate recognition in selective autophagy and the ubiquitin–proteasome systemBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014
- 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/εAmino Acids, 2012
- Casein kinase 1: Complexity in the familyThe International Journal of Biochemistry & Cell Biology, 2011
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- The ubiquitin-proteasome systemJournal of Biosciences, 2006